We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
+18.4%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$1.28B
AUM Growth
+$253M
Cap. Flow
+$143M
Cap. Flow %
11.17%
Top 10 Hldgs %
13.47%
Holding
1,446
New
471
Increased
321
Reduced
302
Closed
327

Top Buys

Rank Stock Value
1
VRNA
Verona Pharma
VRNA
+$16.8M
2
U icon
Unity
U
+$14M
3
AIFC
AI Financial Corp
AIFC
+$13.8M
4
CYBR
CyberArk
CYBR
+$12.6M
5
NSC icon
Norfolk Southern
NSC
+$11.7M

Sector Composition

Rank Sector Weight
1 Technology 21.32%
2 Communication Services 11.38%
3 Healthcare 11.08%
4 Consumer Discretionary 10.37%
5 Financials 9.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DBA icon
701
Invesco DB Agriculture Fund
DBA
$1.24B
$321K 0.03%
+12,000
New +$320K
MLTX icon
702
MoonLake Immunotherapeutics
MLTX
$1.47B
$321K 0.03%
+44,779
New +$2.33M
EMB icon
703
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$14.9B
$321K 0.03%
+3,370
New +$316K
SF
704
Stifel
SF
$12.6B
$319K 0.02%
+4,217
New +$316K
TXT icon
705
Textron
TXT
$15.3B
$319K 0.02%
+3,773
New +$307K
SLB icon
706
SLB Ltd
SLB
$78.9B
$318K 0.02%
+9,250
New +$322K
SCCO icon
707
Southern Copper
SCCO
$167B
$318K 0.02%
2,721
-581
-18% -$56.4K
NX icon
708
Quanex
NX
$967M
$317K 0.02%
+22,327
New +$418K
MANH icon
709
Manhattan Associates
MANH
$11.4B
$317K 0.02%
1,547
+366
+31% +$77.4K
TSLL icon
710
Direxion Daily TSLA Bull 2X ETF
TSLL
$3.32B
$317K 0.02%
+15,000
New +$203K
SAIL
711
SailPoint Inc
SAIL
$11B
$316K 0.02%
+14,327
New +$300K
FSLR icon
712
First Solar
FSLR
$25.7B
$316K 0.02%
1,431
-7,115
-83% -$1.37M
AVTX icon
713
Avalo Therapeutics
AVTX
$1.06B
$313K 0.02%
+24,628
New +$212K
APPN icon
714
Appian
APPN
$2.55B
$311K 0.02%
10,168
+1,182
+13% +$35.5K
BNY
715
Bank of New York Mellon
BNY
$108B
$310K 0.02%
+2,849
New +$291K
VMEO
716
DELISTED
Vimeo
VMEO
$310K 0.02%
+39,953
New +$197K
AURA icon
717
Aura Biosciences
AURA
$796M
$309K 0.02%
+50,000
New +$327K
EXTR icon
718
Extreme Networks
EXTR
$3.09B
$308K 0.02%
+14,939
New +$297K
SXC icon
719
SunCoke Energy
SXC
$799M
$308K 0.02%
37,700
+6,696
+22% +$53.3K
EVR icon
720
Evercore
EVR
$11.5B
$307K 0.02%
909
+17
+2% +$5.33K
AXS icon
721
AXIS Capital
AXS
$7.43B
$307K 0.02%
3,200
-1,937
-38% -$188K
AFRM icon
722
Affirm
AFRM
$25.3B
$306K 0.02%
+4,194
New +$319K
OR icon
723
OR Royalties Inc
OR
$6.32B
$306K 0.02%
+7,647
New +$239K
MAX icon
724
MediaAlpha
MAX
$830M
$306K 0.02%
+26,892
New +$297K
EPHE icon
725
iShares MSCI Philippines ETF
EPHE
$147M
$304K 0.02%
+12,250
New +$322K

Similar funds

Prelude Capital Management's Q3 2025 Portfolio in Review

As of Q3 2025, Prelude Capital Management held 1,446 positions worth $1.28B, up 25% from $1.03B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Prelude Capital Management deployed $143M of net new capital in Q3 2025, opening 471 new positions and adding to 321 existing holdings. Its largest new stake was Verona Pharma: 160,565 shares worth $17.1M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 19% a quarter earlier, followed by Communication Services and Healthcare.

On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $13.2M trimmed.

  • Prelude Capital Management's largest Q3 2025 buy was Verona Pharma: 160,565 shares worth $17.1M.
  • Prelude Capital Management added most to Amazon in Q3 2025, an estimated $11.4M increase.
  • Prelude Capital Management's biggest Q3 2025 reduction was Meta Platforms (Facebook), cutting an estimated $13.2M.
  • Prelude Capital Management fully exited Amedisys in Q3 2025, selling an estimated $8.89M.
  • Prelude Capital Management's ten largest holdings make up 13% of its $1.28B portfolio in Q3 2025.
  • Prelude Capital Management opened 471 new positions and closed 327 in Q3 2025.
  • Prelude Capital Management's portfolio value rose 25% quarter-over-quarter to $1.28B.

Based on Prelude Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.